Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, has made progress at its U.S. site in Milford, MA transforming the facility into a state-of-the-art, multi-product site. Following the company’s largest expansion, the newest manufacturing line is fully operational, and the company has a growing number of client projects that are being successfully onboarded and delivered. The newest production line at the Milford, MA site represents the largest expansion in Rentschler Biopharma’s...